2-((2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-6a,8a,10,10-tetramethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetaldehyde;(6?,11?,16?)-6,9-Difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxopregna-1,4-dien-21-al; 6?,9?-Difluoro-11?,16?,17?-trihydroxypregna-1,4-diene-3,20-dione-21-al-16,17-acetonide; 6?,9-Difluoro-11?,16?,17-trihydroxy-3,20-dioxopregna-1,4-dien-21-al Cyclic 16,17-acetal with Acetone; Fluocinolone Acetonide-21-aldehyde;
Fluocinolone Acetonide EP Impurity Dis a fully characterized chemical compound used as a reference standard of API Fluocinolone Acetonide. The standard offered is compliant with regulatory guidelines.Fluocinolone Acetonide EP Impurity Dis used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 13242-30-3
